Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter?
The vasodilator-stimulated phosphoprotein-phosphorylation (VASP-P) flow-cytometric assay is mainly used in clinical trials to measure thienopyridine effects. However, there are remarkable differences in the reported optimal cut-offs, ranging from 48-61% platelet reactivity index (PRI). We therefore...
Saved in:
Published in | Thrombosis and haemostasis Vol. 107; no. 3; p. 538 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.03.2012
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The vasodilator-stimulated phosphoprotein-phosphorylation (VASP-P) flow-cytometric assay is mainly used in clinical trials to measure thienopyridine effects. However, there are remarkable differences in the reported optimal cut-offs, ranging from 48-61% platelet reactivity index (PRI). We therefore investigated whether a lack of standardisation might explain the differences in the cut-offs. We measured VASP-P in 62 individuals. PRI was calculated using the mean, geometric mean and median fluorescence intensities (FI). Stability of the blood-samples (time-to-assay, 0-2 days) and stability of the processed samples (0-120 minutes) within the recommended time-span were tested. Time-to-assay significantly influenced the PRI (p<0.001): the PRI from mean FI after two days was lower compared to values on day 1 (52 ± 22.9 vs. 57.7 ± 24.1, p<0.001). The PRI from the geometric mean FI after two days was lower compared to day 0 as well as day 1 (51.3 ± 23 vs. 58.2 ± 24.2 and vs. 59.1 ± 23.7, both p<0.001). The PRI from median FI was stable over time (day 0: 59.1 ± 25%, day 1: 59.7 ± 24.1% and day 2: 56.4 ± 23.9%, all p=ns). Furthermore, the lag time of the processed samples significantly altered the PRI (all p<0.001) with a maximum difference for PRI based on geometric mean FI after 90 minutes compared to baseline (Δ=3.92%PRI, p<0.001). The differences in the reported cut-offs might be explained by a lack of standardisation. More precise standardisation is inevitable, as the PRI significantly depends on the method of calculation, the time-to-assay as well as on the lag time after processing. Tolerably stable results were obtained for the PRI from the median FI. |
---|---|
AbstractList | The vasodilator-stimulated phosphoprotein-phosphorylation (VASP-P) flow-cytometric assay is mainly used in clinical trials to measure thienopyridine effects. However, there are remarkable differences in the reported optimal cut-offs, ranging from 48-61% platelet reactivity index (PRI). We therefore investigated whether a lack of standardisation might explain the differences in the cut-offs. We measured VASP-P in 62 individuals. PRI was calculated using the mean, geometric mean and median fluorescence intensities (FI). Stability of the blood-samples (time-to-assay, 0-2 days) and stability of the processed samples (0-120 minutes) within the recommended time-span were tested. Time-to-assay significantly influenced the PRI (p<0.001): the PRI from mean FI after two days was lower compared to values on day 1 (52 ± 22.9 vs. 57.7 ± 24.1, p<0.001). The PRI from the geometric mean FI after two days was lower compared to day 0 as well as day 1 (51.3 ± 23 vs. 58.2 ± 24.2 and vs. 59.1 ± 23.7, both p<0.001). The PRI from median FI was stable over time (day 0: 59.1 ± 25%, day 1: 59.7 ± 24.1% and day 2: 56.4 ± 23.9%, all p=ns). Furthermore, the lag time of the processed samples significantly altered the PRI (all p<0.001) with a maximum difference for PRI based on geometric mean FI after 90 minutes compared to baseline (Δ=3.92%PRI, p<0.001). The differences in the reported cut-offs might be explained by a lack of standardisation. More precise standardisation is inevitable, as the PRI significantly depends on the method of calculation, the time-to-assay as well as on the lag time after processing. Tolerably stable results were obtained for the PRI from the median FI. |
Author | Bruno, Veronika Wojta, Johann Huber, Kurt Freynhofer, Matthias K Willheim, Martin Hübl, Wolfgang |
Author_xml | – sequence: 1 givenname: Matthias K surname: Freynhofer fullname: Freynhofer, Matthias K email: matthias.freynhofer@meduniwien.ac.at organization: 3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria. matthias.freynhofer@meduniwien.ac.at – sequence: 2 givenname: Veronika surname: Bruno fullname: Bruno, Veronika – sequence: 3 givenname: Martin surname: Willheim fullname: Willheim, Martin – sequence: 4 givenname: Wolfgang surname: Hübl fullname: Hübl, Wolfgang – sequence: 5 givenname: Johann surname: Wojta fullname: Wojta, Johann – sequence: 6 givenname: Kurt surname: Huber fullname: Huber, Kurt |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22274403$$D View this record in MEDLINE/PubMed |
BookMark | eNo1jztPAzEQhF0EkQd01Mh_wGCvH8nRIBQBQYpEE2gj33kNRnfnk-0U-fccSihWu9-sZqSZk0kfeyTkRvA7IQy_322EYLxi3ICckBmXijMDSk_JPOcfzoVRlb4kUwBYKsXljJRPm6MLrS0xsVxCdxhPdHT4jnmcIcWCoWdnTMfxG2JPbc72SENPh5GxL5mOYtPGIbj4lbB9oC5iprnY3tnkQj7ZOlsKpscrcuFtm_H6vBfk4-V5t96w7fvr2_ppyxqtqsKgbqyX1i29BFx5WXtoatDWCYnLP0SvjTTGay0AnOfO1Eqs6gqMd4gNLMjtKXc41B26_ZBCZ9Nx_18ffgFX-2Ed |
CitedBy_id | crossref_primary_10_1160_TH11_12_0876 crossref_primary_10_1016_j_jcin_2014_09_007 crossref_primary_10_3390_jcm12031149 crossref_primary_10_1016_j_jcin_2013_06_011 crossref_primary_10_3109_09537104_2012_704650 crossref_primary_10_1160_TH12_10_0758 crossref_primary_10_5482_HAMO_13_11_0055 crossref_primary_10_1007_s10354_012_0148_2 crossref_primary_10_1080_09537104_2018_1478399 crossref_primary_10_1111_j_1538_7836_2012_04838_x crossref_primary_10_1160_TH15_02_0179 crossref_primary_10_3109_09537104_2013_827781 crossref_primary_10_1517_14656566_2014_953054 crossref_primary_10_1016_j_ijcard_2014_04_208 crossref_primary_10_3109_09537104_2012_689037 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1160/TH11-09-0623 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 22274403 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 0R~ 0VX 123 1KJ 4.4 53G 5RE AAQQT ABJNI ABOCM ACGFO ACGFS ACNUY AENEX AFFNX AGCGI AHRSK ALMA_UNASSIGNED_HOLDINGS BR6 C45 CGR CS3 CUY CVF DU5 EBS ECM EIF EJD F5P H13 J5H NPM OVD P2P RTC RTE SJN TEORI X7M ZGI ZXP |
ID | FETCH-LOGICAL-c549t-2bcaf3ad7f32e8f3bf2cb25ad13e7f3bfef56366f55122df0d6b418b926fdeec2 |
ISSN | 0340-6245 |
IngestDate | Mon Jul 21 05:59:29 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c549t-2bcaf3ad7f32e8f3bf2cb25ad13e7f3bfef56366f55122df0d6b418b926fdeec2 |
PMID | 22274403 |
ParticipantIDs | pubmed_primary_22274403 |
PublicationCentury | 2000 |
PublicationDate | 2012-03-01 |
PublicationDateYYYYMMDD | 2012-03-01 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Thrombosis and haemostasis |
PublicationTitleAlternate | Thromb Haemost |
PublicationYear | 2012 |
SSID | ssj0016495 |
Score | 2.1260068 |
Snippet | The vasodilator-stimulated phosphoprotein-phosphorylation (VASP-P) flow-cytometric assay is mainly used in clinical trials to measure thienopyridine effects.... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 538 |
SubjectTerms | Blood Specimen Collection - standards Blood Specimen Collection - statistics & numerical data Cell Adhesion Molecules - metabolism Cell Separation Coronary Artery Disease - diagnosis Coronary Artery Disease - drug therapy Coronary Artery Disease - epidemiology Flow Cytometry Humans Microfilament Proteins - metabolism Observer Variation Phosphoproteins - metabolism Phosphorylation - drug effects Platelet Activation - drug effects Platelet Function Tests - methods Platelet Function Tests - standards Platelet Function Tests - statistics & numerical data Prospective Studies Reference Standards Ticlopidine - administration & dosage Ticlopidine - adverse effects Ticlopidine - analogs & derivatives Vasodilator Agents - metabolism |
Title | Vasodilator-stimulated phosphoprotein-phosphorylation assay in patients on clopidogrel: does standardisation matter? |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22274403 |
Volume | 107 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2RUJcKt60POQDtyqwdRw3y6WCCrRCKqdt6a2KXyQiiVfN9lD-En-SGdvJRktBhcNGG1uxksxnZ2Y88w0hrw2gSAuVJ4WQWcIlzxM5kzJhqTlkIuNGzjB3-OSLmJ_yz-fZ-WTycxS1dLWSb9SPG_NK_keq0AZyxSzZf5DsMCg0wH-QLxxBwnC8lYzPis7pqka7OYGp2mApLlAgl6Xr4OcpGKo2iaeX1yHsbR_U5cJn-0VOVb9hoDBzSjuwvmt0EmhnusHNECN-9hvPxbkRCrgoL10jHfKaoA--LEzj4MKuGiWWmOu2dDaAwxcYr4pu7V9F8gPvsD0zSNT7ff2hqOq6NKHcc6A7GECI-_sfjqX3X391tf1WxC9wdGBgJEgfwdUnbmEGAgusksOiHGrhRvSloyU2C2wwvy_9AmMlF3N0-SKxQkhjHqFg2XgYYPIv59Nb9G4QcfddW2QLTBKssYqOobhhJbgv8DM8S59jIaZvx7eE3NNxmA07xuszi_tkJxoi9H1A1QMyMe1Dcvckhlo8IqubwUX_Di7qwUWrlvbgotA4Atc7itCiG9CiAVpHj8npp4-L43kSS3QkKuOzVcKkKmxa6EObMpPbVFqmJMsKfQBzHU-NzUQqhAXFnDFtp1pIfpDLGRNWG6PYE7LdutY8IzTTnr9QKhiGW9DaBRgPAj0WWuVS6V3yNLyvi2XgYbno3-TeH3uek3trxL0gdyxMfPMStMiVfOXl9wv8DXiw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vasodilator-stimulated+phosphoprotein-phosphorylation+assay+in+patients+on+clopidogrel%3A+does+standardisation+matter%3F&rft.jtitle=Thrombosis+and+haemostasis&rft.au=Freynhofer%2C+Matthias+K&rft.au=Bruno%2C+Veronika&rft.au=Willheim%2C+Martin&rft.au=H%C3%BCbl%2C+Wolfgang&rft.date=2012-03-01&rft.issn=0340-6245&rft.volume=107&rft.issue=3&rft.spage=538&rft_id=info:doi/10.1160%2FTH11-09-0623&rft_id=info%3Apmid%2F22274403&rft_id=info%3Apmid%2F22274403&rft.externalDocID=22274403 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-6245&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-6245&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-6245&client=summon |